Membership Directory
AstraZeneca R&D Boston
Category: Drug Development
Phone: 781-839-4000
Fax: 781-839-4500
Website: http://www.astrazeneca.com/
As one of the world’s top five pharmaceutical organizations, AstraZeneca is on the front lines of drug discovery and development. With nine R&D centers around the world, our focus on developing new therapies within the gastrointestinal, cardiovascular, respiratory, cancer infectious disease, and pain control areas has resulted in some of the most effective pharmaceuticals available. The new, state-of-the-art AstraZeneca R&D Boston facility, located in Waltham, Mass., reflects the innovative environment of AstraZeneca’s leading-edge pharmaceutical research. With the addition of the Waltham facility, AstraZeneca is better equipped than ever to deliver new drugs that ensure a higher quality of life for people around the globe. The research conducted at AstraZeneca R&D Boston focuses on developing innovative new therapies within the cancer and infectious disease areas. In addition, AstraZeneca R&D Boston is home to AstraZeneca’s cutting-edge North American Enabling Science and Technology Center. • Infectious Disease research – The need for new antimicrobial agents is urgent. In Boston, AstraZeneca is leading the search for new drugs by applying the powerful new technology known as Genomics. When Genomics is coupled with molecular biology, the Company can quickly identify the potential novel drug targets of a microorganism. AstraZeneca R&D Boston is applying these advances to our pursuit of new classes of antimicrobials that hold promise in combating the growing occurrence of drug-resistant bacteria and fungi. • Cancer research – AstraZeneca R&D Boston adds important new resources to the Company’s world-leading research efforts in cancer. Collaborative efforts within cancer research and chemical and biological technology development are strengthening the Company’s contributions to the creation of life-enhancing drugs for cancer patients. • Enabling Science & Technology – Boston is the home of AstraZeneca’s North American Enabling Science and Technology (EST) Center, a powerful source of innovation to the Company’s worldwide pharmaceutical R&D organization. The EST Center combines advanced, high-throughput technologies and novel scientific approaches in the following areas: Drug Target Identification and Validation, Combinatorial and Parallel Chemical Synthesis, Bioinformatics, Cheminformatics, and Mathematical Modeling of Human Physiology and Disease.
Back to list



PHONE: 617.674.5100
EMAIL: